Trademark: 88553807
Word
RENMAB
Status
Pending
Status Code
774
Status Date
Monday, February 14, 2022
Serial Number
88553807
Mark Type
4000
Filing Date
Wednesday, July 31, 2019
Published for Opposition
Tuesday, August 17, 2021

Trademark Owner History
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO. - Owner At Publication
Beijing Biocytogen Co., Ltd. - Original Applicant

Classifications
5 (Based on Intent to Use) Medical immunoassay reagent; medical drugs being medical preparations for the treatment of diseases; medical nutrition for the treatment of diseases; medical biological preparations for the treatment of diseases; drugs for treating cancer; medicines for human purposes, namely, for the treatment of diseases; biochemical drugs for the treatment of diseases; immunologic stimulants for medical use for the treatment of diseases; bulk drugs for the treatment of diseases, namely, Active Pharmaceutical Ingredient ("API"); medical diagnostic preparation
1 (Based on 44(e)) Chemical additives for insecticides; nitrogen fertilizer; food preservative chemicals; biological preparations not for medical or veterinary use; radioactive elements for scientific purposes; diagnostic preparations not for medical or veterinary use; protein in raw material form for scientific and medical research, and industrial use; plasticizers being industrial chemicals; industrial adhesives; industrial chemicals
31 (Based on 44(e)) Live experimental animal; live animals; live poultry; live hamster; live swine; living trees; plant seeds; hay; living plants
42 (Based on 44(e)) Drug development services; drug evaluations being pharmaceutical research; pharmaceutical research; implementation of early assessment in new drug development fields to develop pharmaceutical preparations and medicines; development of pharmaceutical preparations and medicines; clinical trials being pharmaceutical and scientific research services; package design; research and development of antibodies; research and development of new products for others; products development for others; consulting services in technology development fields; biological research and analyses; biochemistry research and analyses; biotechnology research
The wording "RENMAB" has no meaning in a foreign language.

Trademark Events
Feb 14, 2022
Opposition Instituted No. 999999
Sep 15, 2021
Extension Of Time To Oppose Received
Aug 17, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 17, 2021
Published For Opposition
Jul 28, 2021
Notification Of Notice Of Publication E-Mailed
Jul 9, 2021
Approved For Pub - Principal Register
Jul 9, 2021
Teas/Email Correspondence Entered
Jul 9, 2021
Correspondence Received In Law Office
Jul 6, 2021
Teas Response To Suspension Inquiry Received
Feb 17, 2021
Automatic Update Of Assignment Of Ownership
Jan 5, 2021
Notification Of Inquiry As To Suspension E-Mailed
Jan 5, 2021
Inquiry To Suspension E-Mailed
Jan 5, 2021
Suspension Inquiry Written
Dec 2, 2020
Suspension Checked - To Attorney For Action
May 29, 2020
Notification Of Letter Of Suspension E-Mailed
May 29, 2020
Letter Of Suspension E-Mailed
May 29, 2020
Suspension Letter Written
May 12, 2020
Teas/Email Correspondence Entered
May 12, 2020
Correspondence Received In Law Office
May 8, 2020
Assigned To Lie
May 5, 2020
Teas Response To Office Action Received
Nov 5, 2019
Notification Of Non-Final Action E-Mailed
Nov 5, 2019
Non-Final Action E-Mailed
Nov 5, 2019
Non-Final Action Written
Oct 28, 2019
Assigned To Examiner
Aug 14, 2019
New Application Office Supplied Data Entered
Aug 3, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24